We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
168 hedge funds and large institutions have $2.21B invested in Acadia Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,357% more call options, than puts
Call options by funds: $335M | Put options by funds: $23M
84% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 19
19% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 53
8% more funds holding
Funds holding: 155 → 168 (+13)
6% more capital invested
Capital invested by funds: $2.08B → $2.21B (+$132M)
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
Holders
168
Holders Change
+13
Holders Change %
+8.39%
% of All Funds
4.85%
Holding in Top 10
6
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-45.45%
% of All Funds
0.17%
New
35
Increased
63
Reduced
53
Closed
19
Calls
$335M
Puts
$23M
Net Calls
+$312M
Net Calls Change
-$26.6M
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$39.6M |
| 2 |
Jennison Associates
New York
|
+$37.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.2M |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$24.9M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$24.5M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$23.3M |
| 2 |
VAM
Visium Asset Management
New York
|
-$22.2M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$15.8M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.6M |
| 5 |
CCI
Columbus Circle Investors
|
-$10.8M |
